In a study done by Leung et al. non-small cell lung carcinomas expressing CD44 were positive for stemness markers Oct-4, Sox-2, and Nanog, but CD44- cells did not express these stemness markers, suggesting a putative role of CD44 in TICs [34]. The gene discussed is SOX2; the disease is non-small cell lung carcinoma.